Agenus Inc. (AGEN) Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization
Agenus specializes in developing comprehensive oncology combat systems by combining various immunotherapy methods. This chart for the company on GURU.Markets demonstrates an EV/EBITDA multiple, which currently stands at 9.38. However, military conflicts and sanctions are hindering international research and the logistics of biomaterials. Strict patents and colossal FDA certification costs ensure business security, creating a barrier to entry for smaller players.
agenusbio.com - analytical breakdowns and key metrics (AGEN)
- current price and projected stock value:
- market capitalization details:
- book value of equity indicators:
- debt level and financial liquidity data:
- business earnings and investment ratios data:
AGEN - Company Net Income|Expected Profit Agenus|AGEN - Price to Earnings Multiple|Projected Price to Earnings Agenus|AGEN - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Agenus, Inc|AGEN - Operating income before deduction of amortization|Net earnings per share (EPS TTM) Agenus|AGEN - Net earnings per share (EPS TTM)|Quarterly EPS earnings growth agenusbio.com|AGEN - Net earnings per share change in current year|Earnings growth forecast for next year Agenus
Initial company analysis:Agenus Inc AGEN
The multiple is calculated as the ratio of enterprise value (EV) to earnings before interest, taxes, depreciation, and amortization (EBITDA). It determines the payback period of assets, accounting for debt load and the ability to generate real cash flow. The hybrid outsourcing model of Agenus optimizes clinical trial costs, thereby reducing operational risks. Analyzing the EV/EBITDA multiple trend allows for a real-time assessment of the issuer's credit resilience amid market turbulence.
Competitors of Agenus
EV/EBITDA Multiple ARGX (Argenx)|Total Company Value to Operating Income Before Depreciation Ratio BioNTech Pharma (BNTX)|ABVX - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|admabiologics.com (ADMA) - Enterprise Value to EBITDA Ratio|Protagonist (PTGX) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio Immunovant Inc|Enterprise Value to EBITDA Ratio KNSA|EV/EBITDA Multiple Grifols Biemat|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Adaptive Biotechnologies (ADPT)|celldex.com - Enterprise Value to Operating Income Before Depreciation|EV/EBITDA Multiple AUPH (Aurinia Pharmaceuticals Inc.)|BioCryst Pharmaceuticals, Inc. (BCRX) - Company Value to EBITDA|Vera Pharma - EV/EBITDA Multiple|DNTH - EV/EBITDA Multiple|PHVS: EV/EBITDA Multiple|Enterprise Value to EBITDA Multiple AbCellera ABCL|TRML (Tourmaline Bio) - EV/EBITDA Multiple|Company Value to EBITDA Precigen Inc PGEN|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Pharming (PHAR)|Nektar Corp - Enterprise Value to Operating Income Before Depreciation|Upstream Bio Inc - Enterprise Value to EBITDA Ratio|EV/EBITDA Multiple zenasbio.com ZBIO|IMNM - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Total Company Value to Operating Income Before Depreciation Ratio Gossamer Bio Inc GOSS|KALV: EV/EBITDA Multiple|Septerna Pharma (SEPN) - EV/EBITDA Multiple|PVLA (Pieris Pharmaceuticals) - EV/EBITDA Multiple|SVRA - Enterprise Value to EBITDA Multiple|EV/EBITDA Multiple RIGL|ANAB - Company Value to EBITDA|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Astria Pharma ATXS|ENGN: Enterprise Value to Operating Income Before Depreciation|RAPT - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to Operating Income Before Depreciation Ratio JBIO|ACRS: EV/EBITDA Multiple|Kyverna Therapeutics Inc. - Business Value to Operating Income Before Depreciation|TLSA (Tiziana Life Sciences PLC) - EV/EBITDA Multiple|EV/EBITDA Multiple Cabaletta Bio Inc|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Ventyx Biosciences (VTYX)|THTX (theratech.com) - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Avalo Therapeutics AVTX|ELDN - Enterprise Value to EBITDA Ratio|Climb Bio, Inc. - EV/EBITDA Multiple|ZURA - EV/EBITDA Multiple|ATYR (aTyr Pharma, Inc.) - Enterprise Value to EBITDA Ratio|Adagene Inc. - Business Value to Operating Income Before Depreciation|IMA (ImageneBio) - EV/EBITDA Multiple|Shattuck Therapeutics (STTK) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Equillium, Inc. (EQ)|Enterprise Value to EBITDA Ratio connectbiopharm.com CNTB|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Immunic IMUX|ATRA - Enterprise Value to EBITDA Ratio|IFRX: Enterprise Value to EBITDA Ratio|XFOR - EV/EBITDA Multiple|adicetbio.com (ACET) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to Operating Income Before Depreciation CELU|INMB (INmune Bio, Inc.) - EV/EBITDA Multiple|Company Value to EBITDA barinthusbio.com BRNS|EV/EBITDA Multiple KZR|EV/EBITDA Multiple SAB Biotherapeutics Inc. (SABS)|EV/EBITDA Multiple AKTX (Akari Therapeutics plc)|Enterprise Value to EBITDA Multiple Enlivex Therapeutics Ltd|Q32 Bio Corp - EV/EBITDA Multiple|Company Value to EBITDA geovax.com|Edesa Biotech (EDSA) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to Operating Income Before Depreciation IBIO|Enterprise Value to EBITDA Ratio CARM|EV/EBITDA Multiple XTL Bio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Bolt Biotherapeutics (BOLT)|Total Company Value to Operating Income Before Depreciation Ratio hcwbiologics.com|EV/EBITDA Multiple APVO (Aptevo Therapeutics Inc.)|EV/EBITDA Multiple aimimmuno.com AIM|Aditxt Corp - EV/EBITDA Multiple|Enterprise Value to EBITDA Multiple GRI Bio Corporation (GRI)|XRTX: EV/EBITDA Multiple|Company Value to EBITDA reshapelifesciences.com (HIND)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Revelation Biosciences, Inc.|Enterprise Value to Operating Income Before Depreciation INDP (Indaptus Therapeutics Inc)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Scinai (SCNI)|CALI: Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple AFMD (Affimed N.V.)|Business Value to Operating Income Before Depreciation ALLK|HOOKIPA - EV/EBITDA Multiple|IGMS - EV/EBITDA Multiple|iTeos (ITOS) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Ocean Biomedical Corp - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization TC Biopharm|Enterprise Value to EBITDA Ratio thirdharmonicbio.com (THRD)
